Capital Flow Monitor · Sponsors · CIK 2029240
Prana Therapies, Inc.
378 Neptune Avenue, ENCINITAS, CA, 92024 · 858-208-0193
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$40.2M
Sold
$40.2M
% sold
100.0%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | D ·current | 506(b) | $40.2M | $40.2M | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Ben Auspitz — Director, Encinitas, CA
1 other raise
- Antlia Bioscience, Inc. $6.0M of $20.0M · 30.0%
-
Alexis Borisy — Director, Encinitas, CA
1 other raise
- Tango Therapeutics, Inc. $15.0M of $15.0M · 100.0%
- Sheila Gujrathi, M.D. — Executive Officer / Director, Encinitas, CA
- Hector Ortega — Executive Officer, Encinitas, CA
-
Ryan Sullivan — Executive Officer, Encinitas, CA
1 other raise
- Conduit Gaming Inc $57K of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.